Prev:Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma(A25112-19.1005)
Next:PHB2 ameliorates Doxorubicin-induced cardiomyopathy through interaction with NDUFV2 and restoration of mitochondrial complex I function(KTP4003-11.9)